Cadila provides an extensive range of products for the prevention and treatment of cardiovascular diseases (CVD). Our first-in-the-world innovation, Polycap launched in 2009 is a polypill for primary prevention of cardiovascular events and stroke; it is designed to reduce patient pill burden and to improve patient compliance. Our cardiology range also caters to hypertension which is a major contributor to premature deaths related to CVD.
To give you the best possible experience every time you visit our site, we use cookies to identify and store your preferences on your browser. Continuing to browse our site means that you are "ok" with this. Learn more about our privacy policy.
